Amarin reported $36.71M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 32.25B 1.2B Jun/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
Amarin USD 36.71M 8M Sep/2025
AstraZeneca USD 25.03B 1.04B Sep/2025
DBV Technologies USD 39.82M 972K Sep/2025
GlaxoSmithKline GBP 15.68B 855M Sep/2025
Halozyme Therapeutics USD 15.36M 3.33M Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Neurocrine Biosciences USD 119.9M 15.3M Sep/2025
Novartis USD 4.56B 49M Sep/2025